Merck, AstraZeneca Receive FDA Extension on Lynparza New Drug Application Date

Retrieved on: 2022-12-15 18:34:10

Tags for this article:

Click the tags to see associated articles and topics

Merck, AstraZeneca Receive FDA Extension on Lynparza New Drug Application Date. View article details on hiswai:

Excerpt

By Denny Jacob Drugmaker Merck & Co. and pharmaceutical company AstraZeneca PLC on Thursday said the Food and Drug Administration will extend the ...

Article found on: www.marketscreener.com